Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
View Patent ↗Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal cord region to address low back pain without creating unwanted sensory and/or motor side effects. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.
1. A spinal cord stimulation system, the system comprising:
an implantable signal generator configured to generate a non-paresthesia-producing therapy signal, wherein the therapy signal includes a plurality of sequential biphasic pulses having pulse widths in a pulse width range from 25 microseconds to 166 microseconds; and
a signal delivery device configured to be electrically coupled to the implantable signal generator and to deliver the therapy signal to a target location in the patient's spinal cord.
2. The system of claim 1 , wherein at least a portion of the therapy signal is at a frequency in a frequency range from 1.5 kHz to 100 kHz.
3. The system of claim 2 , wherein the frequency range is from 3 kHz to 20 kHz.
4. The system of claim 1 , wherein at least a portion of the therapy signal is at a frequency of 10 kHz.
5. The system of claim 1 , wherein at least a portion of the therapy signal is delivered at a current amplitude in a current amplitude range from 0.5 mA to 10 mA.
6. The system of claim 1 , wherein the target location is at a vertrebral level between T9 and T12, inclusive.
7. A spinal cord stimulation system for reducing or eliminating pain in a patient, the system comprising:
an implantable signal generator configured to generate a therapy signal at an amplitude that at least partially reduces the, patient's sensation of pain without generating paresthesia, wherein the therapy signal includes a plurality of sequential biphasic pulses having a pulse width in a pulse width range from 25 microseconds to 166 microseconds, and the amplitude is in a current amplitude range from 0.1 mA to 20 mA; and
a signal delivery device electrically coupleable to the implantable signal generator and configured to deliver the therapy signal to the patient's spinal cord.
8. The system of claim 7 , wherein the implantable signal generator generates the therapy signal at a duty cycle.
9. The system of claim 8 , wherein at least a portion of the therapy signal is at a frequency in a frequency range from 3 kHz to 20 kHz and is applied throughout the length of an on period in the duty cycle.
10. The system of claim 8 , wherein at least a portion of the therapy signal is at a frequency in a frequency range from 3 kHz to 20 kHz and is applied during a portion of an on period in the duty cycle.
11. The system of claim 8 , wherein the duty cycle is 50-100%.
12. The system of claim 7 , wherein at least a portion of the therapy signal is at a frequency in a frequency range from 3 kHz to 20 kHz.
13. The system of claim 7 , wherein the current amplitude range is from 0.5 mA to 10 mA.
14. The system of claim 7 , wherein the current amplitude is suprathreshold.
15. The system of claim 7 , wherein at least a portion of the therapy signal is a biphasic square-wave signal.
16. The system of claim 7 , wherein the signal delivery device is a percutaneous lead configured to be implanted in the patient's epidural space.
17. The system of claim 5 , wherein the signal delivery device is a paddle lead configured to be surgically implanted proximate to a target location.
18. A spinal cord modulation system for reducing or eliminating back and/or leg pain in a patient, without using paresthesia or tingling to mask the patient's sensation of the pain, the system comprising:
an implantable signal generator having a housing and one or more processors disposed within the housing, wherein the one or more processors are configured to generate a therapy signal that at least partially reduces the patient's sensation of pain without generating paresthesia, wherein the therapy signal includes a plurality of sequential biphasic square-wave pulses, with the pulses having a pulse width in a pulse width range from 25 microseconds to 166 microseconds, and a current amplitude in a current amplitude range from 0.5 mA to 10 mA; and
an elongated electrical lead electrically coupled to the implantable signal generator and configured to be implanted in the patient's epidural space, wherein the electrical lead includes two or more electrodes configured to deliver the therapy signal to the patient's spinal cord.
19. The system of claim 18 , wherein the implantable signal generator generates the therapy signal at a duty cycle.
20. The system of claim 19 , wherein a frequency in a frequency range from 1.5 kHz to 100 kHz is applied throughout the length of an on-period in the duty cycle.
21. The system of claim 19 , wherein a frequency in a frequency range from 1.5 kHz to 100 kHz is applied during a portion of an on period in the duty cycle.
22. The system of claim 19 , wherein the duty cycle is 50-100%.
23. The system of claim 18 , wherein at least a portion of the therapy signal is at a frequency in a frequency range from 1.5 kHz to 100 kHz.
24. The system of claim 23 , wherein the frequency range is from 3 kHz to 20 kHz.
25. The system of claim 18 , wherein at least a portion of the therapy signal is at a frequency of 10 kHz.
26. The system of claim 18 , wherein the current amplitude range is from 0.5 mA to 4 mA.
27. The system of claim 18 , wherein the pulse width range is from 30 microseconds to 35 microseconds.
28. The system of claim 18 , wherein the current amplitude is suprathreshold.
29. The system of claim 18 , wherein the elongated electrical lead is a percutaneous lead.
30. The system of claim 18 , wherein the elongated electrical lead is a paddle lead configured to be surgically implanted proximate to a target location in the patient's epidural space.